USD 16.91
(2.61%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 150.17 Million USD | -0.44% |
2022 | 150.83 Million USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | 0.0% |
2019 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 156.98 Million USD | 0.0% |
2024 Q2 | 166.68 Million USD | 0.0% |
2023 FY | 150.17 Million USD | -0.44% |
2023 Q1 | 148.92 Million USD | -1.27% |
2023 Q2 | 147.74 Million USD | -0.79% |
2023 Q4 | 150.17 Million USD | 2.09% |
2023 Q3 | 147.09 Million USD | -0.44% |
2022 Q1 | 132.82 Million USD | 0.0% |
2022 FY | 150.83 Million USD | 0.0% |
2022 Q4 | 150.83 Million USD | -1.35% |
2022 Q3 | 152.88 Million USD | 9.41% |
2022 Q2 | 139.73 Million USD | 5.2% |
2021 Q3 | - USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2021 Q1 | - USD | 0.0% |
2021 Q4 | - USD | 0.0% |
2021 FY | - USD | 0.0% |
2020 FY | - USD | 0.0% |
2020 Q4 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Alcon Inc. | 4.59 Billion USD | 96.73% |
AptarGroup, Inc. | 726.45 Million USD | 79.328% |
Baxter International Inc. | 11.06 Billion USD | 98.643% |
Becton, Dickinson and Company | 14.73 Billion USD | 98.981% |
Bausch + Lomb Corporation | 4.53 Billion USD | 96.686% |
Haemonetics Corporation | 797.56 Million USD | 81.171% |
Envista Holdings Corp | 1.5 Billion USD | 90.042% |
ResMed Inc. | 697.31 Million USD | 78.464% |
Teleflex Incorporated | 1.83 Billion USD | 91.834% |
West Pharmaceutical Services, Inc. | 157.3 Million USD | 4.532% |